Aridis Pharmaceuticals, Inc.
ARDS
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -83.00K | 12.14M | -6.82M | -6.39M | -8.24M |
| Total Depreciation and Amortization | 59.00K | 63.00K | 87.00K | 100.00K | 125.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -250.00K | 0.00 |
| Total Other Non-Cash Items | 876.00K | 279.00K | 850.00K | -353.00K | 1.17M |
| Change in Net Operating Assets | -1.84M | -16.83M | 1.88M | -1.67M | 2.68M |
| Cash from Operations | -983.00K | -4.34M | -4.00M | -8.56M | -4.27M |
| Capital Expenditure | -- | -- | -- | -49.00K | 0.00 |
| Sale of Property, Plant, and Equipment | 0.00 | 14.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 14.00K | -- | -49.00K | 0.00 |
| Total Debt Issued | 750.00K | 1.75M | -- | 0.00 | 0.00 |
| Total Debt Repaid | -1.49M | 1.49M | -1.49M | -1.35M | -450.00K |
| Issuance of Common Stock | 1.73M | 1.00K | 2.06M | 12.61M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -208.00K | -311.00K | -230.00K | -104.00K |
| Cash from Financing | 999.00K | 3.03M | 263.00K | 11.03M | -554.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 16.00K | -1.30M | -3.74M | 2.43M | -4.82M |